Clinical Study on the Treatment of Senile Alzheimer’s Dementia with Sodium Oligomannate Combined with Memantine Hydrochloride

Objective:To analyze the clinical effects of sodium oligomannate combined with memantine hydrochloride in the treatment of senile Alzheimer’s dementia.Methods:Sixty-eight cases of Alzheimer’s dementia treated at the Second People’s Hospital of Fujian University of Traditional Chinese Medicine from March 2020 to March 2022 were selected as the study subjects.The patients were divided into two groups based on different treatment methods:the control group(treated with memantine hydrochloride,34 cases)and the treatment group(treated with sodium oligomannate+memantine hydrochloride,34 cases).Cognitive function,activities of daily living,neurotransmitters,serum intestinal flora metabolic markers,inflammatory factors,neurotrophic factors,and adverse reactions were compared between the two groups.Results:The treatment group showed better cognitive function,quality of life scores,and levels of relevant metabolic markers in the body compared to the control group,with statistically significant differences(P<0.05).The incidence of adverse reactions between the two groups(treatment group:2%;control group:4%)was not statistically significant(χ^(2)=0.731,P=0.393).Conclusion:Sodium oligomannate combined with memantine hydrochloride has better efficacy than the control group for treating senile Alzheimer’s dementia.It significantly improves and restores cognitive function and daily living abilities,benefits neurotransmitter secretion and internal regulation,upregulates the expression of neurotrophic factors,and has fewer adverse reactions,making it a treatment worthy of further clinical promotion and application.

Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis

AIM:To investigate the effects of mesenchymal stem cells(MSCs)on dextran sulfate sodium-induced inflammatory bowel disease(IBD).METHODS:C57BL/6 mice were fed 3.5%(g/L)dextran sulfate sodium.On day seven,the mice received intraperitoneal injections of 1×106 MSCs.The survival rate,disease activity index values,and body weight,were monitored daily.On day ten,colon lengths and histopathologic changes were assessed.In addition,immunoregulatory changes following MSC administration were evaluated by determining the levels of effector T cell responses in the spleen and mesenteric lymph nodes,and the expression levels of inflammatory cytokines in homogenized colons.RESULTS:Intraperitoneal administration of MSCs did not prevent development of colitis and did not reduce the clinicopathologic severity of IBD.No significant difference was evident in either survival rate or disease activity index score between the control and MSCtreated group.Day ten-sacrificed mice exhibited no significant difference in either colon length or histopathologic findings.Indeed,the MSC-treated group exhibited elevated levels of interleukin(IL)-6 and transforming growth factor-β,and a reduced level of IL-10,in spleens,mesenteric lymph nodes,and homogenized colons.The IL-17 level was lower in the mesenteric lymph nodes of the MSC-treated group(P=0.0126).In homogenized colons,the IL-17 and tumor necrosis factor-α(P=0.0092)expression levels were also lower in the treated group.CONCLUSION:MSC infusion provided no significanthistopathologic or clinical improvement,thus representing a limited therapeutic approach for IBD.Functional enhancement of MSCs is needed in further study.

A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon

AIM： To develop a new formulation with hydroxy propyl methyl cellulose and Shellac coating for extended and selective delivery of butyrate in the ileo-caecal region and colon. METHODS： One-gram sodium butyrate coated tablets containing ^13C-butyrate were orally administered to 12 healbhy subjects and 12 Crohn＇s disease patients and the rate of ^13C-butyrate absorption was evaluated by t3CO2 breath test analysis for eight hours. Tauroursodeoxycholic acid （500 rag） was co-administered as a biomarker of oro-ileal transit time to determine also the site of release and absorption of butyrate by the time of its serum maximum concentration. RESULTS： The coated formulation delayed the ^13C-butyrate release by 2-3 h with respect to the uncoated tablets. Sodium butyrate was delivered in the intestine of all subjects and a more variable transit time was found in Crohn＇s disease patients than in healthy subjects. The variability of the peak ^13CO2 in the kinetic release of butyrate was explained by the inter-subject variability in transit time. However, the coating chosen ensured an efficient release of the active compound even in patients with a short transit time. CONCLUSION： Simultaneous evaluation of breath ^13CO2 and tauroursodeoxycholic acid concentrationtime curves has shown that the new oral formulation consistently releases sodium butyrate in the ileo-cecal region and colon both in healthy subjects and Crohn＇s disease patients with variable intestinal transit time. This formulation may be of therapeutic value in inflammatory bowel disease patients due to the appropriate release of the active compound.

Baeyer-Villiger oxidation of cyclic ketones utilizing potassium peroxydisulfate(K_2S_2O_8) or sodium perborate(NaBO_3) in acidic media

The efficient, green, facile, mild and straightforward conversion procedure for the oxidation of cyclic ketones to lactones at room temperature utilizing potassium peroxydisulfate （K2S2O8） in acidic media is satisfactory to high yields without using traditional chlorinated solvents is reported. This oxidative reagent is cheap and friendly environmental procedure for industrial purposes than use of organic peracids.

Pharmacokinetics,distribution,and excretion of sodium oligomannate,a recently approved anti-Alzheimer's disease drug in China

The National Medical Products Administration has authorized sodium oligomannate for treating mild-to-moderate Alzheimer’s disease.In this study,an LC-MS/MS method was developed and validated to quantitate sodium oligomannate in different biomatrices.The plasma pharmacokinetics,tissue distribution,and excretion of sodium oligomannate in Sprague-Dawley rats and beagle dogs were systematically investigated.Despite its complicated structural composition,the absorption,distribution,metabolism,and excretion profiles of the oligosaccharides in sodium oligomannate of different sizes and terminal derivatives were indiscriminate.Sodium oligomannate mainly crossed the gastrointestinal epithelium through paracellular transport following oral administration,with very low oral bioavailability in rats(0.6%-1.6%)and dogs(4.5%-9.3%).Absorbed sodium oligomannate mainly resided in circulating body fluids in free form with minimal distribution into erythrocytes and major tissues.Sodium oligomannate could penetrate the blood-cerebrospinal fluid(CSF)barrier of rats,showing a constant area under the concentration-time curve ratio(CSF/plasma)of approximately 5%.The cumulative urinary excretion of sodium oligomannate was commensurate with its oral bioavailability,supporting that excretion was predominantly renal,whereas no obvious biliary secretion was observed following a single oral dose to bile duct-cannulated rats.Moreover,only 33.7%(male)and 26.3%(female)of the oral dose were recovered in the rat excreta within 96 h following a single oral administration,suggesting that the intestinal flora may have ingested a portion of unabsorbed sodium oligomannate as a nutrient.

Cellulose nanofiber-derived carbon aerogel for advanced room-temperature sodium–sulfur batteries

Room-temperature sodium–sulfur(RT/Na–S)batteries are regarded as promising large-scale stationary energy storage systems owing to their high energy density and low cost as well as the earth-abundant reserves of sodium and sulfur.However,the diffusion of polysulfides and sluggish kinetics of conversion reactions are still major challenges for their application.Herein,we developed a powerful and functional separator to inhibit the shuttle effect by coating a lightweight three-dimensional cellulose nanofiber-derived carbon aerogel on a glass fiber separator(denoted NSCA@GF).The hierarchical porous structures,favorable electronic conductivity,and three-dimensional interconnected network of N,S-codoped carbon aerogel endow a multifunctional separator with strong polysulfide anchoring capability and fast reaction kinetics of polysulfide conversion,which can act as the barrier layer and an expanded current collector to increase sulfur utilization.Moreover,the hetero-doped N/S sites are believed to strengthen polysulfide anchoring capability via chemisorption and accelerate the redox kinetics of polysulfide conversion,which is confirmed from experimental and theoretical results.As a result,the assembled Na–S coin cells with the NSCA@GF separator showed a high reversible capacity(788.8 mAh g^(−1) at 0.1 C after 100 cycles)and superior cycling stability(only 0.059%capacity decay per cycle over 1000 cycles at 1 C),thereby demonstrating the significant potential for application in high-performance RT/Na–S batteries.

Lithium Pre-cycling Induced Fast Kinetics of Commercial Sb2S3 Anode for Advanced Sodium Storage

Because of the abundant sodium resources and identical fundamental principles, sodium ion batteries(SIBs) are the state-of-the-art alternative for lithium ion batteries. However, the larger ionic radius of Na+causes sluggish reaction kinetics, which directly results in inferior electrochemical performance. In this work, the sodium storage properties of commercial bulk Sb2S3(CSS) were improved by a single lithiation/delithiation cycle obtaining the lithium pre-cycled Sb2S3(LSS). Quantitative analysis reveals that the sodiation/desodiation kinetics of CSS and LSS is mainly diffusion-controlled behavior and capacitive process, respectively. Thus, the reaction kinetics of LSS is promising, which exhibits improved initial coulombic efficiency, stable cycling performance, and high rate capability. In addition, a stable Licontaining solid electrolyte interphase film was formed during the lithiation process, which can prevent continuous consumption of electrolyte during the each sodiation process. These results demonstrate that prelithiation technique should be a potential strategy to promote practical application for SIBs.

Effective Sodium Metabisulfite (Na₂S₂O₅), HCl, Sulfur and Distilled Water for the Removal of Pb, Zn and Cr Contaminated Soil in the Columns Method

This paper presents an evaluation of different dose of Sodium Metabisulfite (0.01 M Na2S2O5), (Na2S2O5) + (0.1 HCl), and Distilled water for the removal of soil contaminated with Pb, Zn and Cr by the column mode. The field soil contained concentrations of Pb (307.31 mg&#8901;kg&#8722;1), Zn (207.77 mg&#8901;kg&#8722;1) and Cr (447.50 mg&#8901;kg&#8722;1). Both (0.01 M Na2S2O5), (Na2S2O5) + (0.1 HCl), and Distilled water were found to be effective on removing (Na2S2O5) Pb, Cr and Zn respectively. (Na2S2O5) + (0.1 HCl) Cr, Zn and Pb respectively. Sulfur Pb, Cr and Zn respectively. The removal rate of Pb, Zn, and Cr varied from 10.35% - 26%, 3.4% - 21.60% and 4.97% - 23.88% for (0.01 M Na2S2O5 respectively. The removal rate of Pb, Zn, and Cr varied from 16.13% - 20.07%, 8.20% - 23.48%, 5.42% - 28.93% for (0.01 M Na2S2O5 + 0.1 M HCl) respectively. The removal rate of Pb, Zn, and Cr varied from 10.20% - 25.5%, 9.55% - 25.13% and 6.04% - 25.54% for (S) respectively.

The Interaction Between Sodium Dodecylsulfate (SDS) and Eriochrome Azurol B (ECAB) or Chromazurol S (CAS)

Introduction In our previous papers,we reported that SDS could produce a strong enhancment effect on chromogenic reaction systems,such as Be;-ECAB,Al;-ECAB,Cu;-ECAB and Pd;-ECAB,but made no effect on the absorption spectra of the systems if ECAB was replaced by CAS.So far, no report on the solubilizing and enhancment effect of anionic surfactant on metallic-acidic triphenylmethane dye system studied by means of NMR has been published.In this paper the interaction be-

采用两步炭化法和熔盐模板法制备N、S共掺杂煤基硬炭及共储钠性能

硬炭因资源丰富、结构稳定及安全性高等优势,已成为钠离子电池常用阳极材料。其中,煤基衍生硬炭受到了广泛的关注。本工作以长焰煤为碳源,硫脲为氮硫源,NaCl为模板,通过两步炭化工艺和杂原子掺杂相结合的方法合成了N和S共掺杂的煤基硬炭(NSPC1200)。两步炭化过程在调节碳微晶结构和扩大层间距方面发挥了重要的作用。N和S的共掺杂调节了炭材料的电子结构,赋予其更多的活性位点;此外,引入NaCl作为模板有助于孔结构的构建,有利于电极和电解质之间的接触,从而实现Na+和电子的有效传输。在协同作用下,样品NSPC1200表现出优异的储钠能力,在20 mA g^(−1)电流密度下呈现314.2 mAh g^(−1)的可逆容量。即使在100 mA g^(−1)下循环200次,仍保持224.4 mAh g^(−1)的比容量。这项工作成功实现了策略性调整煤基炭材料微观结构的目标,最终获得了具有优异的电化学性能的硬炭阳极。

Thermally decarboxylated sodium bicarbonate:Interactions with water vapour,calorimetric study

Isothermal titration calorimetry （ITC） was used to study interactions between water vapour and the surface of thermally converted sodium bicarbonate （NaHCO3）. The decarboxyla- tion degree of the samples was varied from 3% to 35% and the humidity range was 54-100%. The obtained enthalpy values were all exothermic and showed a positive linear correlation with decarboxylation degrees for each humidity studied. The critical humidity, 75% （RHo）, was determined as the inflection point on a plot of the mean-AH kJ/mole Na2CO3 against RH. Humidities above the critical humidity lead to complete surface dissolution. The water uptake （m） was determined after each calorimetric experiment, complementing the enthalpy data. A mechanism of water vapour interaction with decarboxylated samples, including the formation of trona and Wegscheider＇s salt on the bicarbonate surface is proposed for humidities below RHo.

OBSERVATION OF THE EFFECT OF S－（－）USNIC ACID SODIUM ON TRICHOMONAS VAGINALIS BY TRANSMISSION ELECTRON MICROSCOPE

This paper reports the ultrastructural changes of trichomonas vaginaiis (T. vag. ) under the action of s-(-)usnic acid sodium in vitro. These changes can be shown by the following results:At first, the degranulation of the rough endoplasmic reticulum (RER) took place, the polyribosomes disaggregated. And then, the Golgi complex and the endoplasmic reticulum dilated. The cytoplasmic matrix presented and inhomogeneous apperance. Finally, the biomembrane loosed and fractured.The cell nuclei presented the karyorrhexis.

Bones and Crohn’s:No benefit of adding sodium fluoride or ibandronate to calcium and vitamin D

AIM: To compare the effect of calcium and cholecalciferol alone and along with additional sodium fluoride or ibandronate on bone mineral density (BMD) and fractures in patients with Crohn's disease (CD). METHODS: Patients (n =148) with reduced BMD (T-score < -1) were randomized to receive cholecalciferol (1000 IU) and calcium citrate (800 mg) daily alone(group A, n = 32) or along with additional sodium fluoride (25 mg bid) (group B, n = 62) or additional ibandronate (1 mg iv/3-monthly) (group C, n = 54). Dual energy X-ray absorptiometry of the lumbar spine (L1-L4) and proximal right femur and X-rays of the spine were performed at baseline and after 1.0, 2.25 and 3.5 years. Fracture-assessment included visual reading of X-rays and quantitative morphometry of vertebral bodies (T4-L4).RESULTS: One hundred and twenty three (83.1%) patients completed the first year for intention-to-treat (ITT) analysis. Ninety two (62.2%) patients completed the second year and 71 (47.8%) the third year available for per-protocol (PP) analysis. With a significant increase in T-score of the lumbar spine by +0.28 ± 0.35 [95% conf idence interval (CI): 0.162-0.460, P < 0.01], +0.33 ± 0.49 (95% CI: 0.109-0.558, P < 0.01), +0.43 ± 0.47 (95% CI: 0.147-0.708, P < 0.01) in group A, +0.22 ± 0.33 (95% CI: 0.125-0.321, P < 0.01); +0.47 ± 0.60 (95% CI: 0.262-0.676, P < 0.01), +0.51 ± 0.44 (95% CI: 0.338-0.682, P < 0.01) in group B and +0.22 ± 0.38 (95% CI: 0.111-0.329, P < 0.01), +0.36 ± 0.53 (95% CI: 0.147-0.578, P < 0.01), +0.41 ± 0.48 (95% CI: 0.238-0.576, P < 0.01) in group C, respectively, during the 1.0, 2.25 and 3.5 year periods (PP analysis), no treatment regimen was superior in any in- or between-group analyses. In the ITT analysis, similar results in all in- and between-group analyses with a significant in-group but non-significant between-group increase in T-score of the lumbar spine by 0.38 ± 0.46 (group A, P < 0.01), 0.37 ± 0.50 (group B, P < 0.01) and 0.35 ± 0.49 (group C, P < 0.01) was observed. Follow-up in ITT analysis was still 2.65 years. One vertebral fracture in the sodium fluoride group was detected. Study medication was safe and well tolerated. CONCLUSION: Additional sodium fluoride or ibandronate had no benefit over calcium and cholecalciferol alone in managing reduced BMD in CD.

Synthesis of Sodium 2-[4(S)-4-Amido-3-oxo-2-isoxazolidinyl]-5-oxo-2-tetrahydrofurancarboxylate and Its Antibacterial Activities

Lactivicin,a novel inhibitor of bacterial cell wall synthesis,was isolated from the culture fil-trates of microorganism YK-258 and YK-422.It exhibits biological activities similar to those ofthe β-lactam antibiotics,although it does not have a β-lactam ring in its molecule.Since the discovery of lactivicin,hundreds of its derivatives have been synthesized.

基于NaIO_(3)转化NaIO_(4)回用合成S-甘油醛缩丙酮及其寡聚研究

S-甘油醛缩丙酮是合成手性药物的重要中间体。以L-抗坏血酸为原料,经缩酮化,硼氢化钠还原,高碘酸钠氧化制得S-甘油醛缩丙酮,收率为46.8%;探讨了含碘酸钠母液转化成高碘酸钠以循环套用,回收率为83.90%;初步考察了S-甘油醛缩丙酮的聚合度与时间的关系,并推测其寡聚化合物的结构和反应机理;用^(1)H NMR、IR和LC-MS等对化合物结构进行表征。

SCR催化剂再生钨酸钠溶液中硫、硅、磷杂质的去除研究

为提高SCR催化剂再生过程中的产物钨酸钠中所含硅、磷、硫杂质的去除效率,通过结合氧化脱硫法、镁盐法和明胶絮凝法,对含钨、钒的钨酸钠富集液进行净化后探究了沉淀剂的加入量、溶液的pH、反应时间及反应温度对杂质去除效率的影响,确定了最佳工艺参数。在最佳工艺参数条件下,S、Si、P的去除率分别达到92.3%、92.93%和39.23%,钨钒损失率低于10%。

室温固相反应助力制备氮硫共掺杂碳限域的FeCoS_(2)复合物用于高性能钠离子电池负极

利用室温固相自组装反应制备Co和Fe双席夫碱配合物,随后在硫粉存在下中温热处理,使该配合物同时发生热解碳化和固相硫化反应,从而获得N、S共掺杂碳限域的FeCoS_(2)纳米复合物(记为FeCoS_(2)■NSC)。通过粉末X射线衍射、透射电镜、X射线光电子能谱和热重分析技术分别对纳米复合物的物相、形貌结构、组分和含量等进行物理表征,并通过循环伏安、恒电流充放电技术测试其电化学储钠性能。研究结果表明,最优化条件下制备的复合物(FeCoS_(2)■NSC-7001)中FeCoS_(2)粒子的平均尺寸约为3.4 nm,且被均匀限域在N、S共掺杂的碳基体中;该复合物作为钠离子电池负极时,在0.1 A·g^(-1)的电流密度下经过300次充放电循环,其可逆充电比容量仍高达310.4 mAh·g^(-1);即使在5 A·g^(-1)的大电流密度下,其充电比容量也高达146.0 mAh·g^(-1),呈现优异的电化学储钠性能。

海藻酸钠明胶协同固定S-腺苷甲硫氨酸合成酶

以海藻酸钠和明胶为载体,对S-腺苷甲硫氨酸合成酶进行固定化。再用戊二醛对其进一步交联,增强固定化酶的稳定性。考察了海藻酸钠和明胶质量分数、CaCl2质量分数、酶和载体比例以及交联剂戊二醛体积分数等因素对固定化酶的影响。结果表明,最佳固定化条件为:海藻酸钠质量分数2.0%、明胶质量分数1.0%、CaCl2质量分数4.0%、固定化酶量为2.5 g/L凝胶、戊二醛体积分数0.6%。交联固定化酶热稳定性得到大幅度提高,在50℃下保温5 h仍保留72%的活力,而游离酶则完全失活。交联固定化酶在碱性溶液中的稳定性较高,在pH=8.0～9.0的缓冲液中4℃保温10 h酶活性仍保留87%以上。将交联固定化酶用于S-腺苷甲硫氨酸的合成,连续反应8批次后酶活性仍保留65%。

亚砷酸钠对SH-SY5Y细胞生长和3MST表达的影响

神经母细胞瘤是儿童最常见的恶性肿瘤之一。因其恶性程度高，手术加化疗的方案对于侵润性的神经母细胞瘤效果不佳。砷，俗名砒霜，很早被用来治疗急性粒性白血病。现在发现砷对神经母细胞瘤、胶质瘤，以及来源于肝脏、前列腺、肾脏、子宫颈和胆囊等固体肿瘤也有效［1］。然而，其作用机制尚未完全明了。有报道，肿瘤细胞H2 S合成酶表达上调［2］。那么，砷是否可通过下调H2 S合成酶的表达发挥抗癌作用？本实验采用SH－SY5Y细胞和亚砷酸钠（ NaAsO2）对此问题进行了探讨。

(S)-(+)-5-羟甲基-2-吡咯烷酮的合成方法改进

通过实验证明在(S)-(+)-5-羟甲基-2-吡咯烷酮合成中,以硼氢化钠为还原剂时,所得产品产率和纯度都有大幅度提高;且实验操作简单方便,适合工业化。